Latest Insider Transactions at Allovir, Inc. (ALVR)
This section provides a real-time view of insider transactions for Allovir, Inc. (ALVR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allovir, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allovir, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,205
-3.33%
|
$258,485
$17.82 P/Share
|
|
Jul 02
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,586
-3.73%
|
$353,134
$19.99 P/Share
|
|
Jun 03
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
508
-0.11%
|
$11,176
$22.87 P/Share
|
|
May 25
2021
|
Malcolm Brenner |
SELL
Bona fide gift
|
Indirect |
818,663
-100.0%
|
-
|
|
May 18
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,201
-3.22%
|
$334,422
$22.8 P/Share
|
|
May 17
2021
|
Diana Brainard Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+45.21%
|
-
|
|
May 10
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
150,000
-6.1%
|
$3,300,000
$22.75 P/Share
|
|
Apr 05
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,212
-3.53%
|
$418,876
$23.89 P/Share
|
|
Mar 22
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,750
-0.72%
|
$93,750
$25.97 P/Share
|
|
Mar 16
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,025
-0.12%
|
$90,750
$30.0 P/Share
|
|
Mar 11
2021
|
John Robert Wilson Director |
SELL
Open market or private sale
|
Indirect |
16,662
-0.09%
|
$516,522
$31.25 P/Share
|
|
Mar 10
2021
|
John Robert Wilson Director |
SELL
Open market or private sale
|
Indirect |
72,743
-0.26%
|
$2,255,033
$31.61 P/Share
|
|
Mar 09
2021
|
John Robert Wilson Director |
SELL
Open market or private sale
|
Indirect |
110,595
-0.59%
|
$3,428,445
$31.5 P/Share
|
|
Mar 05
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
48,091
-1.13%
|
$1,538,912
$32.31 P/Share
|
|
Mar 04
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
49,598
-1.38%
|
$1,785,528
$36.03 P/Share
|
|
Mar 03
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
17,915
-0.64%
|
$662,855
$37.72 P/Share
|
|
Mar 03
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
15,988
-0.23%
|
$591,556
$37.95 P/Share
|
|
Mar 02
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
512
-0.11%
|
$18,944
$37.93 P/Share
|
|
Mar 02
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
12,658
-0.45%
|
$481,004
$38.25 P/Share
|
|
Mar 02
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
14,994
-0.21%
|
$569,772
$38.23 P/Share
|
|
Mar 01
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
21,694
-1.13%
|
$824,372
$38.7 P/Share
|
|
Mar 01
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
9,518
-0.19%
|
$361,684
$38.82 P/Share
|
|
Mar 01
2021
|
Edward Miller General Counsel |
SELL
Open market or private sale
|
Indirect |
6,000
-1.52%
|
$228,000
$38.86 P/Share
|
|
Mar 01
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,932
-0.6%
|
$225,416
$38.91 P/Share
|
|
Mar 01
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
32,854
-0.46%
|
$1,248,452
$38.84 P/Share
|
|
Feb 23
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
8,489
-0.22%
|
$331,071
$39.95 P/Share
|
|
Feb 23
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,199
-0.06%
|
$163,761
$39.66 P/Share
|
|
Feb 23
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,118
-0.21%
|
$82,602
$39.75 P/Share
|
|
Feb 23
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
8,850
-0.09%
|
$345,150
$39.64 P/Share
|
|
Feb 22
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
800
-1.22%
|
$34,400
$43.14 P/Share
|
|
Feb 22
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
11,423
-0.39%
|
$479,766
$42.59 P/Share
|
|
Feb 22
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,706
-0.12%
|
$239,652
$42.19 P/Share
|
|
Feb 22
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,800
-0.28%
|
$117,600
$42.17 P/Share
|
|
Feb 22
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
14,321
-0.2%
|
$601,482
$42.59 P/Share
|
|
Feb 19
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
11,990
-1.2%
|
$491,590
$41.78 P/Share
|
|
Feb 19
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
7,541
-0.3%
|
$309,181
$41.75 P/Share
|
|
Feb 19
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,165
-0.83%
|
$170,765
$41.71 P/Share
|
|
Feb 19
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
13,233
-0.54%
|
$542,553
$41.79 P/Share
|
|
Feb 18
2021
|
Jeffrey S Bornstein |
SELL
Open market or private sale
|
Indirect |
20,583
-98.03%
|
$823,320
$40.83 P/Share
|
|
Feb 18
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
6,757
-0.22%
|
$270,280
$40.5 P/Share
|
|
Feb 18
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
8,942
-0.12%
|
$357,680
$40.47 P/Share
|
|
Feb 18
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,085
-0.14%
|
$83,400
$40.59 P/Share
|
|
Feb 18
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
741
-0.56%
|
$28,899
$39.87 P/Share
|
|
Feb 18
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,700
-0.04%
|
$108,000
$40.38 P/Share
|
|
Feb 17
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,496
-0.69%
|
$699,840
$40.11 P/Share
|
|
Feb 17
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,320
-0.85%
|
$92,800
$40.32 P/Share
|
|
Feb 17
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,286
-0.03%
|
$89,154
$39.92 P/Share
|
|
Feb 17
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
5,165
-0.13%
|
$206,600
$40.48 P/Share
|
|
Feb 17
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
7,460
-0.1%
|
$290,940
$39.99 P/Share
|
|
Feb 16
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,050
-2.14%
|
$128,100
$42.24 P/Share
|